Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer — Stella

Recruiting

Back to Anaplastic Thyroid Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Russia

Saint Petersburg State University Hospital, Saint Petersburg

Key details

Phase

Safety & dosing

Sponsor

Saint Petersburg State University, Russia

Enrollment target

~20 participants

Started

March 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov